NYSEARCA:LABU Direxion Daily S&P Biotech Bull 3x Shares (LABU) Price, Holdings, & News → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free LABU Stock Alerts $89.27 -2.71 (-2.95%) (As of 03:09 PM ET) Add Compare Share Share Today's Range$88.68▼$94.2950-Day Range$86.05▼$174.1252-Week Range$48.40▼$176.99Volume1.51 million shsAverage Volume2.98 million shsMarket Capitalization$881.09 millionAssets Under Management$917.14 millionDividend Yield0.60%Net Expense Ratio0.96% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Get Direxion Daily S&P Biotech Bull 3x Shares alerts: Email Address About Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.Read More LABU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LABU ETF News HeadlinesApril 21, 2024 | americanbankingnews.comDirexion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Shares Up 3.3%April 14, 2024 | americanbankingnews.comDirexion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Trading Down 4.8%April 24, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinApril 2, 2024 | investorplace.comThe 3 Best Leveraged ETFs for April 2024March 21, 2024 | msn.comDirexion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.1606March 4, 2024 | seekingalpha.comLABU: A Really Bad DriftJanuary 22, 2024 | finance.yahoo.comDirexion Daily S&P Biotech Bull 3X Shares (LABU)December 16, 2023 | seekingalpha.comLABU: Buy As The Biotech Sector Starts A New Bull Market (Technical Analysis)April 24, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinDecember 10, 2023 | seekingalpha.comLABU: Tool For Swing TradersSee More Headlines Receive LABU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bull 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABU Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings162 Fund Statistics Assets Under Management$886.57 million Average Daily Volume$2.54 million Discount/Premium-0.05% Leveraged3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume9,314 Put Options4,945 Call Options4,369 Short Interest1,080,000 shs Miscellaneous Outstanding Shares9,870,000Beta3.19 Creation Unit50,000 Creation Fee$250.00 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Direxion Daily S&P Biotech Bull 3x Shares ExpensesTypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.56%0.54%0.50%0.51%Other Expenses0.21%0.40%0.54%0.64%0.58%Total Expense0.96%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.53%-0.55%-0.68%-0.57%Net Expense0.96%0.60%0.60%0.57%0.58% Direxion Daily S&P Biotech Bull 3x Shares (LABU) Holdings & ExposureTop 10 LABU HoldingsS&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 44.63%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 38.04%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 37.66%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 32.85%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 29.15%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 22.33%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: 20.69%DREYFUS GOVT CASH MAN INSHolding Weight: 18.01%GOLDMAN FINL SQ TRSRY INST 506Holding Weight: 7.64%Alpine Immune Sciences(NASDAQ:ALPN)Holding Weight: 1.34%LABU Sector ExposureLABU Industry ExposureFull Holdings Details Similar ETFsInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RSPHiShares U.S. Healthcare Providers ETFNYSEARCA:IHFInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RYHFirst Trust NYSE Arca Biotechnology Index FundNYSEARCA:FBTiShares U.S. Pharmaceuticals ETFNYSEARCA:IHEInstitutional OwnershipTB Alternative Assets Ltd.Bought 76,700 shares on 4/15/2024Ownership: 0.044%Traynor Capital Management Inc.Bought 3,142 shares on 4/12/2024Ownership: 0.003%Tower Research Capital LLC TRC Sold 323,032 shares on 2/13/2024Ownership: 0.017%CIBC Private Wealth Group LLCSold 90,250 shares on 2/13/2024Ownership: 0.003%Parallel Advisors LLCSold 31,945 shares on 2/12/2024Ownership: 0.001%View All Institutional Transactions LABU ETF - Frequently Asked Questions How have LABU shares performed in 2024? Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $121.97 at the start of the year. Since then, LABU shares have decreased by 26.8% and is now trading at $89.27. View the best growth stocks for 2024 here. What does LABU invest in? Direxion Daily S&P Biotech Bull 3x Shares is a equity fund issued by Direxion. LABU focuses on health care investments and follows the S&P Biotechnology Select Industry Index. The fund's investments total to approximately $917.14 million assets under management. What stocks does Direxion Daily S&P Biotech Bull 3x Shares hold? LABU invests in 160 holdings. Some of the stocks in their portfolio include Alpine Immune Sciences (ALPN), Exact Sciences (EXAS), Revolution Medicines (RVMD), Cytokinetics (CYTK), BioMarin Pharmaceutical (BMRN), Crinetics Pharmaceuticals (CRNX), Natera (NTRA), Exelixis (EXEL), Roivant Sciences (ROIV) and Cerevel Therapeutics (CERE). What is the management fee for Direxion Daily S&P Biotech Bull 3x Shares? Direxion Daily S&P Biotech Bull 3x Shares' management fee is 0.75% and has other expenses of 0.21%. The net expense ratio for LABU is 0.96%. When did Direxion Daily S&P Biotech Bull 3x Shares' stock split? Direxion Daily S&P Biotech Bull 3x Shares's stock reverse split before market open on Monday, December 4th 2023. The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Direxion Daily S&P Biotech Bull 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), NVIDIA (NVDA), Direxion Daily S&P Biotech Bear 3x Shares (LABD), Alibaba Group (BABA), ProShares UltraPro QQQ (TQQQ), Advanced Micro Devices (AMD), Direxion Daily Semiconductors Bull 3x Shares (SOXL), Boeing (BA), Gilead Sciences (GILD). Who are Direxion Daily S&P Biotech Bull 3x Shares' major shareholders? Direxion Daily S&P Biotech Bull 3x Shares' stock is owned by many different retail and institutional investors. Top institutional investors include TB Alternative Assets Ltd. (0.04%) and Traynor Capital Management Inc. (0.00%). How do I buy shares of Direxion Daily S&P Biotech Bull 3x Shares? Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:LABU) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
